Update from a data point 3-mo in on a high T clinical trial
Brief bio- diagnosed at 46 Gleason 9/10; started ADT. MRI indicated surgery was not an option; lymph system involved and other masses beyond the prostate. Brought out the big guns: 12 weeks of heavy chemo and simultaneous radiation for 35-40 days. Months pass then PSA rise and found a spot to rib bone, did targeted radiation on the spot and started Zytiga. Months pass PSA flirting with Zero then Zytiga started to fail (3 years in now) new spots to ribs. Started the High T trial. Stopped Zytiga and applied. 100 mg testosterone gel (2 packs) each morning. Stayed on Lupron to control T levels.
Starting on the trial my PSA was 20 and I had 3 spots to the ribs. Three months of high T (1000-1200) my PSA was 69, the three existing (assuming adt resistant pc) were noticeably improved and did not brighten up with the contrast/radioactive stuff , however I also got 3 new bright spots to bone (not too big though) per the study I was switched to Xtandi so just starting that now.
My analysis: after much worry about the PSA value I finally decided not to worry about that during the trial. The scans were mixed with notable improvement on existing areas of PC on bone but also new spots to bone. My PC has a broad range of genetic diversity and the mixed expression may reflect that.
The more interesting will be next three months as the HighT May resensitize the PC androgen receptors for the heavy smack down that the Xtandi is going to bring.
After 3 years of ADT, highT felt great. Not emotional; body hair growing back; parts working again, had to buy deodorant again, gained bone density and good muscle mass.
Back and ready for the next fight. I’ve got mountains to climb and kids to raise- F*** PC- I’m gonna be putting this dragon back into his cave.
Chugach
We